课题基金 / 基金详情

Investigation of molecular mechanisms of Sox9 transcriptional factory during enchandral ossification

Investigation of molecular mechanisms of Sox9 transcriptional factory during enchandral ossification
掌骨骨化过程中Sox9转录工厂的分子机制研究
批准号:
17209059
负责人:
YONEDA Toshiyuki
金额:
$29.95万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

YONEDA Toshiyuki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tb investigate the molecular mechanism by which Sox9 plays an essential role in chondrocyte differentiation, we established a gene screening system for identifying the members of Sox9 transcriptional factory. Using this system, we could identify a calcium ion channel, TRPV_4, as a member of Sox9 transcriptional factory, and found that TRPV4 upregulated expression and function of Sox9, thereby stimulating chondrocyte differentiation. We further screened cDNA library generated from chondrogenic cell line, ATDC5, and isolated the Znf219 cDNA. Whole mount in situ and RT-PCR analyses indicated that Znf219 is specifically expressed in limb bud of E12.5 embryo mice and chondrocytes. Co-immunoprecipitation experiments indicated that Znf219 physically interacts with Sox9. Moreover, we found that Znf219 co-localized with Sox9 in the nucleus. These results indicated that Znf219 forms transcriptional factory in the nucleus. To understand the functional role of Znf219 m chondrocyte differentiation, we next examined the effect of overexpression of Zof219 on chondrocyte differentiation. We found that overexpression of Znf219 stimulated the chondrogenic activity of Sox9. In contrast, overexpression of a dominant negative Znf219 markedly inhibited chondrocyte differentiation induced by Sox9. Furthermore, knockdown of Znf219 using micro RNA system suppressed chondrocyte differentiation. Collectively, our results demonstrated that Znf219 might play an important role in Sox9-regulated chondrocyte differentiation.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
CCAAT/enhancer binding protein β isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes
CCAAT/增强子结合蛋白 β 亚型、富含肝脏的抑制蛋白,调节成骨细胞和脂肪细胞的定向
DOI: --
发表时间: 2005
期刊: Mol Cell Biol 25
影响因子: --
作者: [Hata, K, Nishimura, R, Ueda, M, Ikeda, F, Matsubara, T, lchide, F, Hisada, K, Nokubi, T, Yamaguchi, A, Yoneda, T]
通讯作者: T
β-Trcp1ユビキチン化システムによるIhh/Gli2誘導性骨芽細胞分化の制御
β-Trcp1 泛素化系统对 Ihh/Gli2 诱导的成骨细胞分化的调节
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [和田 誠大, ら]
通讯作者:
Biology of cancer-induced bone diseases
癌症引起的骨疾病的生物学
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Yoneda, T]
通讯作者: T
Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
在 4T1/luc 小鼠乳腺癌模型中,5-脱氧-5-氟尿苷和卡培他滨优先抑制骨转移。
DOI: --
发表时间: 2005
期刊: Oncol Report 14
影响因子: --
作者: [Hiraga T, Hata K, Ikeda F, Kitagaki J, Fujimoto-Ouchi K, Tanaka Y, Yoneda T.]
通讯作者: Yoneda T.
33
    Molecular mechanim of cancer-associated bone pain caused by protons
    • 批准号:
      23390422
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      YONEDA Toshiyuki
    • 依托单位:
    Identification of genes involved in biological crosstalk between cancer and bone
    • 批准号:
      23659870
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2011
    • 负责人:
      YONEDA Toshiyuki
    • 依托单位:
    Integrative Study of transcriptional network systems during enchondral ossification
    • 批准号:
      20229010
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $136.53万
    • 财政年份:
      2008
    • 负责人:
      YONEDA Toshiyuki
    • 依托单位:
    Cross talk between bone microenvironment and metastatic cancer cell
    • 批准号:
      17014058
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $27.78万
    • 财政年份:
      2005
    • 负责人:
      YONEDA Toshiyuki
    • 依托单位: